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Metastatic carcinoma to the uterine cervix from colorectal cancer, through haematogenous or lymphatic spread,
is extremely rare. We report the case of a 59 year old woman in whom cervical metastasis was diagnosed after
13 months of follow-up for a sigmoid adenocarcinoma, confirmed by immunohistochemical study, with a review of
the literature. This case illustrates that abnormal gynecologic symptoms can reveal a disease progression on patients
who suffer colorectal cancer.
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Metastases to the female genital tract from extragenital
malignancies are very uncommon, and the most common
extra-genital primary sites are breast and gastrointestinal
system [1,2]. Common metastatic sites of colorectal cancer
include the liver, lung, lymph nodes and peritoneum, but
the rarest would be the uterine cervix [3,4]. We report in
this article a case of metastatic adenocarcinoma from a sig-
moid primary to the uterine cervix, with a review of litera-
ture on uterine cervix metastasis from colorectal cancer.Case presentation
A 59-year-old woman presented in our department with
spinal cord compression at the fifth thoracic vertebrae
(T5) and epiduritis, in order to receive radiotherapy on
vertebral metastasis from a primary well-differentiated
adenocarcinoma of the sigmoid that was diagnosed
one year earlier. The patient was initially operated in
September 2012 undergoing a laparotomic sigmoidect-
omy, post-operative cytopathology concluded in a pT4 N2
M0 stage with negative margins (R0 resection). She received
eight cycles of adjuvant chemotherapy (Capecitabine +
Oxaliplatine) after that time at the Day-hospital of the* Correspondence: berhili.soufiane@gmail.com
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nificant adverse drug effects. During this period, phys-
ical examination and computed tomography (CT) did
not detect any local or distant relapse of the disease.
In September 2013, the patient reported whitish vagi-
nal discharges lasting for three months earlier. In our
department, physical examination did not find any
neurological deficit but rather back pain lasting for
15 days due to spinal metastasis. Gynecologic examin-
ation was painful and found an easy bleeding ulcerative
cervical tumor measuring approximately 6 cm with vagi-
nal and bilateral parametrial involvement at rectal digital
examination. Thoracic-abdominal-pelvic CT showed T5
spinal cord compression with signs of epiduritis, right
pleurisy, ascites, and cervical mass extended to the cor-
pus and measuring 68 × 70 mm, without bladder or rec-
tal invasion (Figure 1). No secondary lesions were found
in lung or liver. CA 19–9 serum tumor marker rate was
821 U/ml (normal <35 U/ml).
Cervical biopsy was performed and showed a moderately
differentiated adenocarcinoma of colonic origin (Figure 2),
confirmed by immunohistochemical study showing
tumor cells diffusely and strongly positive for CK20 and
CDX2 markers, and negative for CK7 marker (Figure 3).
10 daily fractions of decompression radiotherapy were
scheduled (3 Gy per fraction), but the patient received
only six fractions, she died before completing histd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Computed tomography slice of the patient pelvis
showing a cervico-isthmic mass.
Figure 3 Immunohistochemical study of cervical tumor cells:
Strong nuclear staining of tumor cells by the CDX2 marker.
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brain metastases, asymptomatic at the time of admission.
Cervical tumor has therefore not been treated.
Involvement of the uterine cervix through direct ex-
tension of extra-genital neoplasia is frequent. However,
metastatic carcinoma to the cervix through haematogen-
ous or lymphatic spread is extremely rare [1,3]. Contrary
to ovaries which provide a suitable environment for meta-
static cells, the uterine cervix is rarely the site of metasta-
ses because of its fibrous tissue content, small size,
relatively limited blood flow, and the lymphatic vessels of
the pelvis all draining away from the cervix [5]. Thus, the
uterus is rarely involved accounting for less than 10% of
all cases of metastases to the female genital tract from
extra-genital cancers (3.4% for the uterine cervix alone)
[1]. Only few cases have been reported during the pastFigure 2 Cervical biopsy showing metastatic moderately
differentiated adenocarcinoma cells: Ectocervical mucosa
infiltrated by a carcinomatous proliferation of glands of
varying size and focus of necrosis lined by atypical cells.several decades; the youngest patient was 17 years old [6].
These patients carry a dismal prognosis [7].
The gastrointestinal tract tumors are the most prepon-
derant extra-genital primaries of the uterine cervix me-
tastasis which are the stomach, colon, rectum, breast,
and skin melanoma [8,9].
Nakagami et al. [10], reviewed 27 cervical metastases
from colorectal carcinomas, including a majority of co-
lonic primaries. The average interval between primary
carcinoma and uterine cervix metastasis appearance was
17 months (0–60 months), it was 13 months for our
patient. The average survival after cervical metastasis
diagnosis in Nakagami’s review was 11 months.
In our case, leucorrhea appeared 3 months before the
diagnosis of metastasis. Gynecological symptoms follow-
ing medical history of colorectal cancer should be taken
into consideration in order to refer rapidly patients for
adequate treatment.
Adenocarcinoma histology type represents 0.42 to
11.7% of all cervix carcinomas [11], however the inci-
dence of metastatic adenocarcinoma was reported to be
21.6 to 56.9% of cervical adenocarcinoma [11,12].
In pathology study practice, CK7 and CK20 immunoex-
presssions are commonly used in combination to evaluate
immunoreactivity pattern in tumor cells, to confirm the
origin of metastatic disease with unknown primary sites
[13]. CK7 immunoreactivity is observed in tumors of lung,
breast, upper gastrointestinal and pancreatobiliary tract,
endometrium, vagina, and ovary, while tumors of colonic
origin are generally non-reactive to this immunomarker.
CK20 immunoexpression is detected in tumors of gastro-
intestinal tract and urothelium [14]. CDX2 immunoexpres-
sion has proven to be useful in establishing gastrointestinal
origin in metastatic tumors, and has become a useful
addition to the standard immunohistochemical stains list
for carcinomas of unknown primary sites [15].
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panel combining [CK7−/CK20+/CDX2+] is used to con-
firm colonic primary origin [9,13].
In our case, the spread of the tumor to the uterine
cervix might have been caused by lymphatic and/or
hematogenous pathways. Since lesion by direct extension
from the primary sigmoid tumor was excluded (R0 resec-
tion was performed), and lymphatic channels of the cervix
that routinely drain centrifugally, were blocked by surgery
and retrograde flow might occur [5,16,10].
Conclusions
In conclusion, metastases to the female genital tract from
extragenital cancers are uncommon and have a poor prog-
nosis [9,10]. Multidisciplinary approach including immu-
nohistochemical study is required to diagnose these rare
cases, and any gynecological symptoms following medical
history of colorectal carcinoma should bear in mind me-
tastases in order to appropriately assist these patients.
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